DE69839508D1 - Chinolinmorphinan-derivate und ihre medizinische anwendung - Google Patents
Chinolinmorphinan-derivate und ihre medizinische anwendungInfo
- Publication number
- DE69839508D1 DE69839508D1 DE69839508T DE69839508T DE69839508D1 DE 69839508 D1 DE69839508 D1 DE 69839508D1 DE 69839508 T DE69839508 T DE 69839508T DE 69839508 T DE69839508 T DE 69839508T DE 69839508 D1 DE69839508 D1 DE 69839508D1
- Authority
- DE
- Germany
- Prior art keywords
- chinolinmorphinan
- derivatives
- medical application
- medical
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8175697 | 1997-03-31 | ||
PCT/JP1998/001443 WO1998043977A1 (fr) | 1997-03-31 | 1998-03-30 | Derives de quinolinomorphinane et leur usage medical |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69839508D1 true DE69839508D1 (de) | 2008-07-03 |
Family
ID=13755296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69839508T Expired - Fee Related DE69839508D1 (de) | 1997-03-31 | 1998-03-30 | Chinolinmorphinan-derivate und ihre medizinische anwendung |
Country Status (7)
Country | Link |
---|---|
US (1) | US6172078B1 (de) |
EP (1) | EP0911334B1 (de) |
AU (1) | AU6520198A (de) |
CA (1) | CA2256336C (de) |
DE (1) | DE69839508D1 (de) |
TW (1) | TW519543B (de) |
WO (1) | WO1998043977A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2793684B1 (fr) * | 1999-05-17 | 2001-08-10 | Ethypharm Lab Prod Ethiques | Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant |
KR20020012314A (ko) * | 1999-07-19 | 2002-02-15 | 히라이 가쯔히꼬 | 빈뇨 혹은 요실금의 치료 또는 예방제 |
CN1204139C (zh) * | 1999-08-24 | 2005-06-01 | 东丽株式会社 | 神经性疼痛治疗剂 |
EP2319845B1 (de) * | 2008-02-29 | 2013-07-24 | Mallinckrodt LLC | 3-Hydroxymorphinan-Derivate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
JPH03218313A (ja) * | 1989-11-22 | 1991-09-25 | Toray Ind Inc | 脳細胞保護剤 |
JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
CN1043766C (zh) | 1992-09-29 | 1999-06-23 | 东丽株式会社 | 吲哚衍生物及其制法和它们在制备药物中的应用 |
-
1998
- 1998-03-30 AU AU65201/98A patent/AU6520198A/en not_active Abandoned
- 1998-03-30 US US09/194,538 patent/US6172078B1/en not_active Expired - Fee Related
- 1998-03-30 EP EP98911102A patent/EP0911334B1/de not_active Expired - Lifetime
- 1998-03-30 TW TW087104743A patent/TW519543B/zh active
- 1998-03-30 CA CA002256336A patent/CA2256336C/en not_active Expired - Fee Related
- 1998-03-30 DE DE69839508T patent/DE69839508D1/de not_active Expired - Fee Related
- 1998-03-30 WO PCT/JP1998/001443 patent/WO1998043977A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO1998043977A1 (fr) | 1998-10-08 |
US6172078B1 (en) | 2001-01-09 |
EP0911334A4 (de) | 2004-08-25 |
CA2256336C (en) | 2008-01-29 |
CA2256336A1 (en) | 1998-10-08 |
EP0911334B1 (de) | 2008-05-21 |
EP0911334A1 (de) | 1999-04-28 |
AU6520198A (en) | 1998-10-22 |
TW519543B (en) | 2003-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634822D1 (de) | Amid-verbindungen und ihre anwendung | |
DE69838386D1 (de) | Beleuchtungssystem und dessen anwendung | |
DE69929983D1 (de) | Trifluoromethylpyrrolcarboxamide und ihre anwendung als fungizide | |
DE69424853D1 (de) | Morphinan-derivate und ihre medizinische verwendung | |
ATE258811T1 (de) | Blutpumpe und ihre anwendung | |
DE69709366D1 (de) | Medizinische klebende zusammensetzung und verpackung | |
DE69842210D1 (de) | Einführvorrichtung Und Einführungssatz | |
FR11C0020I2 (fr) | Dérives difluoroprostaglandines et leur application | |
DE69842004D1 (de) | Substituierte 2-aminoacetamide und anwendung davon | |
ATA106797A (de) | Anordnung mit bauteilen und bauteile | |
DE69819567D1 (de) | Orthopädische Schnittführung und Hülse | |
DE69611813D1 (de) | Trokar und Kanüle | |
TR199501305A2 (tr) | Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi | |
DE59710422D1 (de) | Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide | |
DE59710580D1 (de) | Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide | |
DE69629987D1 (de) | Funktelefone und Betriebsverfahren | |
DE69704060D1 (de) | Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung | |
DE69831750D1 (de) | Biozide und biozide tücher | |
DE69934141D1 (de) | Mikroorganismus und anwendung desselben | |
DE69903143D1 (de) | Chromanon und thiochromanon derivate | |
NO985227D0 (no) | Alkylaminobenzothiazol og -benzoksazol - derivater | |
ATE226584T1 (de) | 4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- acetamid-derivate, ihre herstellung und therapeutische anwendung | |
DE69932927D1 (de) | Cabapenemderivate, ihre anwendung und ihre zwischenprodukte | |
ATE270272T1 (de) | C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel | |
DE4494231T1 (de) | Therapeutische Zusammensetzung und ihre Anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |